Shanghai HeartCare Medical Technology Corporation Limited

Equities

6609

CNE100004MN5

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
17.92 HKD +5.04% Intraday chart for Shanghai HeartCare Medical Technology Corporation Limited +5.29% -39.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical MT
Shanghai Heartcare Medical Technology Corporation Limited Appoints Xue Zongyu as the Chairperson of the Supervisory Committee CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Board Changes CI
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) dropped from S&P Global BMI Index CI
HeartCare Medical Technology's Loss Narrows in H1 MT
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai HeartCare Medical Technology Corporation Limited Announces Nomination Committee Changes CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Heartcare Medical Technology Corporation Limited Appoints Chen Shaoxiong as A Non-Executive Director CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Chen Gang as Non-Executive Director CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
536,714 Unlisted Foreign Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022. CI
6,731,890 Domestic Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022. CI
24,963,954 H Shares of Shanghai HeartCare Medical Technology Corporation Limited are subject to a Lock-Up Agreement Ending on 19-AUG-2022. CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Resignation of Ouyang Xiangyu as Non-Executive Director CI
Shanghai Heartcare Medical Technology Corporation Limited Appoints Wei Jiawei as an Executive Director CI
Shanghai HeartCare Medical Technology Corporation Limited Voluntary Receives Approval from the National Medical Products Administration for registration application for LAA Occluder CI
Shanghai Heartcare Medical Technology Corporation Limited Receives the Approvals from the National Medical Products Administration of the PRC for the Registration Applications for the Aspiration Catheter and Support Catheter CI
Shanghai HeartCare Medical Technology Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Shanghai HeartCare Medical Technology Corporation Limited Announces Change of Principal Place of Business in Hong Kong CI
Shanghai Heartcare Medical Technology Corporation Limited Announces Executive Changes CI
Shanghai HeartCare Medical Technology Corporation Limited(SEHK:6609) added to S&P Global BMI Index CI
Chinese Regulators OK HeartCare Medical's Registration Application for Neuro-Interventional Product MT
Shanghai Heartcare Medical Technology Corporation Limited Announces Embolic Coil Received NMPA Approval CI
Chart Shanghai HeartCare Medical Technology Corporation Limited
More charts
Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research and development of innovative neuro-interventional medical device. The Company's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The Company's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The Company's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The Company distributes its products within the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.59 CNY
Average target price
27.12 CNY
Spread / Average Target
+63.47%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6609 Stock
  4. News Shanghai HeartCare Medical Technology Corporation Limited
  5. Shanghai HeartCare Offloads Stake in Medical Device Developer Shenji Medical